Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

HOANNJ announces collaboration to enhance cancer care through United Network of US Oncology

Hematology Oncology Associates of Northern New Jersey, P.A. (HOANNJ), an independent physician-owned, single-specialty oncology practice with offices in Morristown and Parsippany, and US Oncology, Inc., the nation's leading integrated oncology company, today announced their new collaboration to protect, expand and enhance patient access to high-quality, evidence-based cancer care and clinical research through the United Network of US Oncology.

1 Dec 2010

Results of pixantrone phase III trial for non-Hodgkin's lymphoma to be presented at Hematology Meeting

Cell Therapeutics, Inc. announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London, the lead investigator for the PIX 301 EXTEND trial will present end of study results for the pixantrone phase III trial in relapsed/refractory aggressive non-Hodgkin's lymphoma at the 52nd Annual Meeting of the American Society of Hematology on Sunday, December 5, 2010 in Orlando, Florida.

1 Dec 2010

USC purchases WaferGen SmartChip system for Molecular Pathways and Drug Discovery center

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today announced that the University of Southern California (USC) has purchased the WaferGen SmartChip system for its USC Center for Molecular Pathways and Drug Discovery to discover and validate biomarkers for pancreatic and colorectal cancer applications to expedite the development of a cancer therapy. USC purchased a solution that includes the SmartChip platform and validated gene panels for biomarker profiling.

1 Dec 2010

New tool helps gauge care for people with neurological disorder

A national conversation continues about the best ways to improve both the quality of medical care and to contain costs. So far, developing quality measurements has focused on primary care or highly prevalent, chronic conditions such as asthma and diabetes. But what about brain disorders? To date, the number of measures that apply to neurologic care has been limited.

1 Dec 2010

Aushon, LightArray enter strategic partnership to provide multiplex biomarker products and services in China

Aushon BioSystems, Inc., a leading provider of multiplex immunoassay products and services for biomarker discovery, development and analysis announced during the ChinaTrials 2010 Summit in Beijing, China, that it has entered into a partnership with LightArray Biotech Company, Ltd., to provide Aushon's comprehensive suite of multiplex biomarker products and services to pharmaceutical, biotechnical, and academic research institutions located in mainland China.

1 Dec 2010

Study shows link between reduced hormone therapy and decline in breast cancer

In a new UCSF study of more than 2 million mammogram screenings performed on nearly 700,000 women in the United States, scientists for the first time show a direct link between reduced hormone therapy and declines in ductal carcinoma in situ (DCIS) as well as invasive breast cancer. The researchers saw such a striking decrease, they believe they also have uncovered indirect evidence that hormones promote breast tumor growth.

1 Dec 2010

Philips Electronics introduces IntelliSpace Portal to improve patient care

Royal Philips Electronics today introduced the Philips IntelliSpace Portal, a multimodality workspace that uses advanced networking capabilities to facilitate collaboration between radiologists and referring clinicians that may lead to faster, more accurate and informed patient care.

From Philips Healthcare 1 Dec 2010

Roche NimbleGen announces NewGene as first certified service provider in the UK

Roche NimbleGen announces that Newcastle-based genomic services provider NewGene Ltd. has officially become a Certified Service Provider (CSP) for NimbleGen Sequence Capture. They will provide services for NimbleGen Sequence Capture Arrays with sequencing on the Genome Sequencer FLX System from 454 Life Sciences, a Roche Company.

1 Dec 2010

GenSpera expands G-202 Phase I safety trial to CTRC at University of Texas Health Science Center

GenSpera, Inc. announced its intention to expand its Phase I safety trial to study G-202 in relapsed, refractory cancer patients to the Cancer Therapy and Research Center (CTRC) at The University of Texas Health Science Center at San Antonio in San Antonio, TX. The expansion is dependent upon a successful review of the clinical protocol by the Health Science Center Institutional Review Board (IRB). The company anticipates admitting the first patient at this site in the first quarter of 2011.

1 Dec 2010

Pfizer awards $2.1 million grant to NCCN to evaluate axitinib in solid tumors

The National Comprehensive Cancer Network has been awarded a $2.1 million grant from Pfizer to develop a program to scientifically evaluate and define the clinical activity of axitinib in various tumor types.

1 Dec 2010

Are vitamin D and calcium supplements needed?

The IOM raised the recommended dietary allowance of vitamin D from the amount cited in their last report, released 13 years ago. It said that although 600 international units (IUs) of vitamin D or more each day is sufficient to maintain bone health in majority. But those aged 71 and older may need as much as 800 IUs daily, the IOM experts say. However 1997 recommendations advised 400 IUs per day for people aged 51 to 70 and 600 IUs per day for those over 70.

30 Nov 2010

Intellikine and MMRC commence INK128 Phase I trial in multiple myeloma

Intellikine, a leader in the development of small molecule drugs targeting the PI3K/mTOR pathway, and the Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a phase I trial of INK128, a novel, orally-available small molecule kinase inhibitor of the TORC1 and TORC2 complexes, in patients with multiple myeloma.

30 Nov 2010

University Hospitals receives $42 million for cancer care

Jane and Lee Seidman have donated $42 million to University Hospitals (UH) the largest gift in the Cleveland-based health system's history. In recognition of this unprecedented generosity, UH is naming the "Jane and Lee Seidman Cancer Center" in their honor.

30 Nov 2010

biOasis commences research agreement with NRC

biOasis Technologies Inc. announced today that it has commenced a sponsored research agreement with the National Research Council of Canada. Under the terms of the agreement, the NRC will evaluate the ability of biOasis' compounds to cross the blood-brain barrier using time-domain in vivo optical imaging.

30 Nov 2010

Philips launches new Ingenuity CT platform for optimizing low-dose imaging

At the 96th annual meeting of the Radiological Society of North America (RSNA) in Chicago, Royal Philips Electronics announced today the new Philips Ingenuity CT (computed tomography) platform, an innovative technology that will help redefine low dose imaging.

From Philips Healthcare 30 Nov 2010

APP to launch Topotecan for Injection following FDA marketing approval

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Topotecan for Injection, and plans to launch immediately.

30 Nov 2010

IRIS announces product acquisition from BioMicro Systems

IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and a provider of high value personalized medicine products and testing services, announced today that it has acquired the assets of a multi-purpose, bench-top instrument platform for automating highly repetitive, manual laboratory protocols for (F)ISH (fluorescence in-situ hybridization) testing and other slide-based cytogenetic applications.

30 Nov 2010

SDI and CSD announce launch of oncology therapeutic market research service

SDI and Cegedim Strategic Data (CSD) announced today that they will jointly launch a new market research service that tracks selling activities in the oncology therapeutic market. The Oncology Selling Audit will be released in January 2011; 2 years of history will be available for reporting and analysis.

30 Nov 2010

NIAID scientists confirm antiviral activity of two lead compounds against HPV

Tamir Biotechnology, Inc. announced today that scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID) reported test results confirming two of our lead compounds showed excellent in vitro antiviral activity and no cellular toxicity at dose levels tested for Human Papillomavirus (HPV).

30 Nov 2010

Siemens to distribute Rcadia's COR Analyzer System

Rcadia Medical Imaging and Siemens Healthcare have entered into an agreement for Siemens to distribute Rcadia's COR Analyzer® System. The COR Analyzer's ability to identify stenotic lesions in Coronary Computed Tomography Angiography (cCTA) studies in combination with Siemens' Syngo®.via CT Cardio-Vascular Engine provides a comprehensive solution for evaluating suspected cardiac patients. The integration of both systems realizes a seamless workflow with enhanced productivity.

30 Nov 2010